Perkins Capital Management Inc. boosted its stake in shares of Rockwell Medical Inc (NASDAQ:RMTI) by 5.9% during the 1st quarter, Holdings Channel reports. The fund owned 445,300 shares of the company’s stock after purchasing an additional 24,800 shares during the period. Rockwell Medical accounts for about 1.7% of Perkins Capital Management Inc.’s holdings, making the stock its 16th largest position. Perkins Capital Management Inc.’s holdings in Rockwell Medical were worth $2,534,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of RMTI. BlackRock Inc. increased its stake in Rockwell Medical by 0.8% during the third quarter. BlackRock Inc. now owns 3,221,245 shares of the company’s stock worth $13,593,000 after acquiring an additional 25,322 shares during the last quarter. Virtu Financial LLC increased its stake in Rockwell Medical by 202.3% during the third quarter. Virtu Financial LLC now owns 36,050 shares of the company’s stock worth $152,000 after acquiring an additional 24,124 shares during the last quarter. Jefferies Group LLC bought a new stake in Rockwell Medical during the third quarter worth approximately $120,000. Rehmann Capital Advisory Group increased its stake in Rockwell Medical by 27.5% during the third quarter. Rehmann Capital Advisory Group now owns 60,192 shares of the company’s stock worth $254,000 after acquiring an additional 12,980 shares during the last quarter. Finally, Rhumbline Advisers increased its stake in Rockwell Medical by 47.3% during the fourth quarter. Rhumbline Advisers now owns 64,421 shares of the company’s stock worth $146,000 after acquiring an additional 20,678 shares during the last quarter. 18.98% of the stock is currently owned by institutional investors.

Several brokerages have weighed in on RMTI. ValuEngine cut Rockwell Medical from a “buy” rating to a “hold” rating in a research note on Wednesday, April 10th. Ifs Securities raised Rockwell Medical from an “outperform” rating to a “strong-buy” rating in a research note on Monday, March 18th.

In other Rockwell Medical news, insider David S. Richmond bought 5,869 shares of the business’s stock in a transaction dated Wednesday, March 27th. The shares were purchased at an average price of $5.59 per share, with a total value of $32,807.71. Following the completion of the purchase, the insider now owns 177,930 shares in the company, valued at approximately $994,628.70. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 18.20% of the company’s stock.

NASDAQ RMTI traded down $0.20 during trading hours on Monday, hitting $4.55. 6,787 shares of the company were exchanged, compared to its average volume of 285,652. Rockwell Medical Inc has a 52 week low of $2.19 and a 52 week high of $6.88. The stock has a market capitalization of $264.94 million, a P/E ratio of -9.66 and a beta of 2.12.

Rockwell Medical (NASDAQ:RMTI) last released its earnings results on Thursday, March 14th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.13) by ($0.02). The business had revenue of $16.85 million for the quarter, compared to the consensus estimate of $16.10 million. Rockwell Medical had a negative net margin of 52.23% and a negative return on equity of 121.54%. As a group, equities analysts predict that Rockwell Medical Inc will post -0.61 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Perkins Capital Management Inc. Has $2.53 Million Holdings in Rockwell Medical Inc (RMTI)” was originally reported by Watch List News and is the property of of Watch List News. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at

About Rockwell Medical

Rockwell Medical, Inc operates as an integrated biopharmaceutical company targeting end-stage renal and chronic kidney diseases in the United States and internationally. The company's lead drug includes Triferic, an iron maintenance therapy that replaces the iron lost by patients during hemodialysis treatment.

Featured Article: How is the S&P 500 index different from the DJIA?

Want to see what other hedge funds are holding RMTI? Visit to get the latest 13F filings and insider trades for Rockwell Medical Inc (NASDAQ:RMTI).

Institutional Ownership by Quarter for Rockwell Medical (NASDAQ:RMTI)

Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with's FREE daily email newsletter.